Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Key products marketed for CNS, oncology, and cardiovascular diseases; first Chinese-developed long-acting injectable antipsychotic (Rykindo, risperidone) approved by FDA; advanced sustained-release technology and transdermal products leading market positions in China and globally; active in gene/cell therapy innovation; 40+ pipeline programs, 80+ countries supplied
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Luye Sike Pharmaceutical Co., Ltd..